Skip to main content
SpringerLink
Log in

Hypertensive Encephalopathy and Acute Blood Pressure Management After Hemorrhagic Stroke

  • Chapter
  • First Online:
Hypertension and Stroke

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 2312 Accesses

Abstract

In the USA, hypertension affects approximately 76% of men and 64% of women by 75 years of age. Among the 73 million individuals in the USA with hypertension, almost 80% are aware of their high blood pressure and 69 % receive antihypertensive treatment. However, less than 50% have controlled blood pressure, placing these individuals at risk for developing neurological emergencies such as hypertensive crisis and intracerebral hemorrhage (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21–181.

    Article  Google Scholar 

  2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.

    Article  Google Scholar 

  3. Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin. 2006;24(1):135–46.

    Article  Google Scholar 

  4. Volhard F, Fahr TH. Die Brightsche Neirenkrankheir: KlinikPathologie Und Atlas. Vol 2. Berlin: Springer Verlag; 1914. pp. 247–65.

    Google Scholar 

  5. Keith NM, Wagener HP, Keronohan JW. The syndrome of malignancy hypertension. Arch Intern Med. 1928;4:264–78.

    Google Scholar 

  6. Oppenheimer B, Fishberg AM. Hypertensive encephalopathy. Arch Intern Med. 1928;41:264–78.

    Google Scholar 

  7. Hebert CJ, Vidt DG. Hypertensive crises. Prim Care. 2008; 35(3):475–87, vi.

    Google Scholar 

  8. Flanigan JS, Vitberg D. Hypertensive emergency and severe hypertension: what to treat, who to treat, and how to treat. Med Clin North Am. 2006;90(3):439–51.

    Article  Google Scholar 

  9. Bennett NM, Shea S. Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases. Am J Public Health. 1988;78(6):636–40.

    Article  Google Scholar 

  10. Ahmed ME, Walker JM, Beevers DG, Beevers M. Lack of difference between malignant and accelerated hypertension. Br Med J (Clin Res Ed. 1986;292(6515):235–7.

    Google Scholar 

  11. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens. 1995;13(8):915–24.

    Article  Google Scholar 

  12. Webster J, Petrie JC, Jeffers TA, Lovell HG. Accelerated hypertension—patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med. 1993;86(8):485–93.

    Google Scholar 

  13. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. 1996;27(1):144–7.

    Google Scholar 

  14. Martin JF, Higashiama E, Garcia E, Luizon MR, Cipullo JP. Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol. 2004;83(2):131–6.

    Article  Google Scholar 

  15. Gardner CJ, Lee K. Hyperperfusion syndromes: insight into the pathophysiology and treatment of hypertensive encephalopathy. CNS Spectr. 2007;12(1):35–42.

    PubMed  Google Scholar 

  16. Healton EB, Brust JC, Feinfeld DA, Thomson GE. Hypertensive encephalopathy and the neurologic manifestations of malignant hypertension. Neurology. 1982;32(2):127–32.

    Google Scholar 

  17. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;118(1):214–27.

    Article  Google Scholar 

  18. Bakker RC, Verburgh CA, van Buchem MA, Paul LC. Hypertension, cerebral oedema and fundoscopy. Nephrol Dial Transplant. 2003;18(11):2424–7.

    Article  Google Scholar 

  19. Pancioli AM. Hypertension management in neurologic emergencies. Ann Emerg Med. 2008;51(3 Suppl):S24–7.

    Google Scholar 

  20. Immink RV, van den Born BJ, van Montfrans GA, Koopmans RP, Karemaker JM, van Lieshout JJ. Impaired cerebral autoregulation in patients with malignant hypertension. Circulation. 2004;110(15):2241–5.

    Article  Google Scholar 

  21. Paulson OB, Waldemar G, Schmidt JF, Strandgaard S. Cerebral circulation under normal and pathologic conditions. Am J Cardiol. 1989;63(6):2C–5C.

    Article  Google Scholar 

  22. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356(9227):411–17.

    Article  Google Scholar 

  23. Verhaar MC, Beutler JJ, Gaillard CA, Koomans HA, Fijnheer R, Rabelink TJ. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J Hypertens. 1998;16(1):45–50.

    Article  CAS  PubMed  Google Scholar 

  24. Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens. 2001;14(11 Pt 1):1154–67.

    Google Scholar 

  25. Strandgaard S, Jones JV, MacKenzie ET, Harper AM. Upper limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res. 1975;37(2):164–7.

    Google Scholar 

  26. Barry DI. Cerebral blood flow in hypertension. J Cardiovasc Pharmacol. 1985;7(Suppl 2):S94–8.

    Google Scholar 

  27. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2(2):161–92.

    Google Scholar 

  28. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992;159(2):379–83.

    Google Scholar 

  29. Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol. 1988;45(10):1078–83.

    Google Scholar 

  30. Hinchey JA. Reversible posterior leukoencephalopathy syndrome: what have we learned in the last 10 years? Arch Neurol. 2008;65(2):175–6.

    Article  Google Scholar 

  31. Schwartz RB, Mulkern RV, Gudbjartsson H, Diffusion-weighted JF. MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol. 1998;19(5):859–62.

    Google Scholar 

  32. Heitsch L, Jauch EC. Management of hypertension in the setting of acute ischemic stroke. Curr Hypertens Rep. 2007;9(6):506–11.

    Article  Google Scholar 

  33. Schneider JP, Krohmer S, Gunther A, Zimmer C. Cerebral lesions in acute arterial hypertension: the characteristic MRI in hypertensive encephalopathy. Rofo. 2006;178(6):618–26.

    Google Scholar 

  34. Kinoshita T, Moritani T, Shrier DA, et al. Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: a pictorial essay. Clin Imaging. 2003;27(5):307–15.

    Article  Google Scholar 

  35. Beausang-Linder M, Bill A. Cerebral circulation in acute arterial hypertension—protective effects of sympathetic nervous activity. Acta Physiol Scand. 1981;111(2):193–9.

    Article  Google Scholar 

  36. Edvinsson L, Owman C, Sjoberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res. 1976;115(3):377–93.

    Article  Google Scholar 

  37. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65(2):205–10.

    Article  Google Scholar 

  38. Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007;33(2):230–6.

    Article  Google Scholar 

  39. Powell ES, Goldman MJ. Posterior reversible encephalopathy syndrome (PRES) in a thirty-six-week gestation eclamptic. J Emerg Med. 2007;33(4):377–9.

    Article  Google Scholar 

  40. de Oliveira RA, Fechine LM, Neto FC, Nicodemus JM, Silva GB Jr, Silva LS. Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis. Int Urol Nephrol. 2008;40(4):1095–8.

    Article  Google Scholar 

  41. Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology. 2009;51:373.

    Article  PubMed  Google Scholar 

  42. Varon J. The diagnosis and treatment of hypertensive crises. Postgrad Med. 2009;121(1):5–13.

    Article  PubMed  Google Scholar 

  43. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131(6):1949–62.

    Article  Google Scholar 

  44. Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review. J Hum Hypertens. 2008;22(9):596–607.

    Article  CAS  PubMed  Google Scholar 

  45. McAllister RG Jr, Schloemer GL, Hamann SR. Kinetics and dynamics of calcium entry antagonists in systemic hypertension. Am J Cardiol. 1986;57(7):16D–21D.

    Article  Google Scholar 

  46. Maxwell CJ, Hogan DB, Campbell NR, Ebly EM. Nifedipine and mortality risk in the elderly: relevance of drug formulation, dose and duration. Pharmacoepidemiol Drug Saf. 2000;9(1):11–23.

    Article  CAS  PubMed  Google Scholar 

  47. Shepherd AM, Ludden TM, McNay JL, Lin MS. Hydralazine kinetics after single and repeated oral doses. Clin Pharmacol Ther. 1980;28(6):804–11.

    Article  Google Scholar 

  48. Kondo T, Brock M, Bach H. Effect of intra-arterial sodium nitroprusside on intracranial pressure and cerebral autoregulation. Jpn Heart J. 1984;25(2):231–7.

    Google Scholar 

  49. Schulz V. Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate. Clin Pharmacokinet. 1984;9(3):239–51.

    Article  Google Scholar 

  50. Vesey CJ, Cole PV, Simpson PJ. Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man. Br J Anaesth. 1976;48(7):651–60.

    Article  Google Scholar 

  51. Pearce CJ, Wallin JD. Labetalol and other agents that block both alpha- and beta-adrenergic receptors. Cleve Clin J Med. 1994;61(1):59–69.

    CAS  PubMed  Google Scholar 

  52. MacCarthy EP, Bloomfield SS. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy. 1983;3(4):193–219.

    CAS  PubMed  Google Scholar 

  53. Amenta F, Tomassoni D, Traini E, Mignini F, VF. Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile. Clin Exp Hypertens. 2008;30(8):808–26.

    Google Scholar 

  54. Varon J. Diagnosis and management of labile blood pressure during acute cerebrovascular accidents and other hypertensive crises. Am J Emerg Med. 2007;25(8):949–59.

    Article  Google Scholar 

  55. Wiest D. Esmolol: a review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinet. 1995;28(3):190–202.

    Article  CAS  PubMed  Google Scholar 

  56. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med. 2001;345(21):1548–57.

    Google Scholar 

  57. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38(6):2001–23.

    Article  Google Scholar 

  58. Counsell C, Boonyakarnkul S, Dennis M, Sandercock P, Bamford J, Burn J, Warlow C. Primary intracerebral haemorrhage in the Oxfordshire Community Stroke Project, 2: prognosis. Cerebrovasc Dis. 1995;5:26–34.

    Article  Google Scholar 

  59. Anderson CS, Chakera TM, Stewart-Wynne EG, Jamrozik KD. Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989-90: incidence and outcome. J Neurol Neurosurg Psychiatry. 1994;57(8):936–40.

    Google Scholar 

  60. Santalucia P. Intracerebral hemorrhage: medical treatment. Neurol Sci. 2008;29(Suppl 2):S271–3.

    Article  Google Scholar 

  61. Shah QA, Ezzeddine MA, Qureshi AI. Acute hypertension in intracerebral hemorrhage: pathophysiology and treatment. J Neurol Sci. 2007;261(1–2):74–9.

    Google Scholar 

  62. Steiner T, Juttler E. American guidelines for the management of spontaneous intracerebral hemorrhage in adults: European perspective. Pol Arch Med Wewn. 2008;118(4):181–2.

    Google Scholar 

  63. Lovelock CE, Molyneux AJ, Rothwell PM. Oxford Vascular Study. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007;6(6):487–93.

    Article  Google Scholar 

  64. Andaluz N, Zuccarello M. Recent trends in the treatment of spontaneous intracerebral hemorrhage: analysis of a nationwide inpatient database. J Neurosurg. 2009;110(3):403–10.

    Google Scholar 

  65. Goldstein LB. Is this patient having a stroke? JAMA. 2005;293:2391–402.

    Google Scholar 

  66. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24(7):987–93.

    Google Scholar 

  67. Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke. 1998;29(7):1352–7.

    Google Scholar 

  68. Tetri S, Juvela S, Saloheimo P, Pyhtinen J, Hillbom M. Hypertension and diabetes as predictors of early death after spontaneous intracerebral hemorrhage. J Neurosurg. 2009;110(3):411–17.

    Google Scholar 

  69. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28(1):1–5.

    CAS  PubMed  Google Scholar 

  70. Silva Y, Leira R, Tejada J, et al. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005;36(1):86–91.

    Article  PubMed  Google Scholar 

  71. Kulkens S, Ringleb P, Diedler J, Hacke W, Steiner T. Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage. Nervenarzt. 2006;77(8):970–87.

    Article  Google Scholar 

  72. Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25(1):32–8.

    Article  Google Scholar 

  73. Arboix A, Roig H, Rossich R, Martinez EM, Garcia-Eroles L. Differences between hypertensive and non-hypertensive ischemic stroke. Eur J Neurol. 2004;11(10):687–92.

    Article  Google Scholar 

  74. Wallace JD, Levy LL. Blood pressure after stroke. JAMA. 1981;246(19):2177–80.

    Article  Google Scholar 

  75. Cheung RT, Hachinski V. Cardiac Effects of Stroke. Curr Treat Options Cardiovasc Med. 2004;6(3):199–207.

    Article  PubMed  Google Scholar 

  76. Makikallio AM, Makikallio TH, Korpelainen JT, et al. Natriuretic peptides and mortality after stroke. Stroke. 2005;36(5):1016–20.

    Article  Google Scholar 

  77. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke. 1998;29(6):1160–6.

    Google Scholar 

  78. Lim JK, Hwang HS, Cho BM, et al. Multivariate analysis of risk factors of hematoma expansion in spontaneous intracerebral hemorrhage. Surg Neurol. 2008;69(1):40–5.

    Article  Google Scholar 

  79. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke. 2007;38(3):1072–5.

    Article  Google Scholar 

  80. Nath FP, Kelly PT, Jenkins A, Mendelow AD, Graham DI, Teasdale GM. Effects of experimental intracerebral hemorrhage on blood flow, capillary permeability, and histochemistry. J Neurosurg. 1987;66(4):555–62.

    Google Scholar 

  81. Kidwell CS, Saver JL, Mattiello J, et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology. 2001;57(9):1611–17.

    Google Scholar 

  82. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57(1):18–24.

    CAS  PubMed  Google Scholar 

  83. Itabashi R, Toyoda K, Yasaka M, et al. The impact of hyperacute blood pressure lowering on the early clinical outcome following intracerebral hemorrhage. J Hypertens. 2008;26(10):2016–21.

    Article  Google Scholar 

  84. Suri MF, Suarez JI, Rodrigue TC, et al. Effect of treatment of elevated blood pressure on neurological deterioration in patients with acute intracerebral hemorrhage. Neurocrit Care. 2008;9(2):177–82.

    Article  Google Scholar 

  85. Honner SK, Singh A, Cheung PT, et al. Emergency department control of blood pressure in intracerebral hemorrhage. J Emerg Med. 2009; DOI: 10.1016/j.jemermed.2009.02.001.

    Google Scholar 

  86. Koch S, Romano JG, Forteza AM, Otero CM, Rabinstein AA. Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care. 2008;8(3):316–21.

    Article  Google Scholar 

  87. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007;6(1):56–66.

    Article  CAS  PubMed  Google Scholar 

  88. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391–9.

    Article  Google Scholar 

  89. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655–711.

    Article  Google Scholar 

  90. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med. 2006;34(7):1975–80.

    Article  Google Scholar 

  91. Liu-Deryke X, Janisse J, Coplin WM, Parker D Jr, Norris G, Rhoney DH. A comparison of nicardipine and labetalol for acute hypertension management following stroke. Neurocrit Care. 2008;9(2):167–76.

    Article  Google Scholar 

  92. Patel RV, Kertland HR, Jahns BE, Zarowitz BJ, Mlynarek ME, Fagan SC. Labetalol: response and safety in critically ill hemorrhagic stroke patients. Ann Pharmacother. 1993;27(2):180–1.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Illinois at Chicago, Chicago, IL, USA

    Rebbeca A. Grysiewicz DO

  2. Department of Neurology and Rehabilitation, College of Medicine at Chicago, University of Illinois, Chicago, IL, USA

    Sean D. Ruland DO

Authors
  1. Rebbeca A. Grysiewicz DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sean D. Ruland DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rebbeca A. Grysiewicz DO .

Editor information

Editors and Affiliations

  1. College of Medicine, Dept. Neurology, University of Illinois, 912 S. Wood Street Room 855 N, Chicago, 60612, Illinois, USA

    Venkatesh Aiyagari

  2. University of Illinois, Department of Neurology and Rehabilitati, College of Medicine at Chicago, S. Wood St 912, Chicago, 60612, Illinois, USA

    Philip B. Gorelick

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Grysiewicz, R.A., Ruland, S.D. (2011). Hypertensive Encephalopathy and Acute Blood Pressure Management After Hemorrhagic Stroke. In: Aiyagari, V., Gorelick, P. (eds) Hypertension and Stroke. Clinical Hypertension and Vascular Diseases. Humana Press. https://doi.org/10.1007/978-1-60761-010-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-010-6_8

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-009-0

  • Online ISBN: 978-1-60761-010-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation